Back | Next |
home / stock / srpt / srpt message board
Subject | By | Source | When |
---|---|---|---|
I'm waiting for 120.00 | Myth | investorshub | 10/14/2021 2:58:07 PM |
Youre right Out at 94.52! | Atown62 | investorshub | 10/13/2021 11:50:18 PM |
wow....down 11.85.... | Myth | investorshub | 10/13/2021 8:02:30 PM |
lol.... so much bullshit...don't even know where to start... | Myth | investorshub | 10/13/2021 6:36:50 PM |
what was good about it ? | Myth | investorshub | 10/13/2021 6:33:16 PM |
there's no truth to any of that.... | Myth | investorshub | 10/13/2021 6:32:09 PM |
Sorry out at 94.52 | Atown62 | investorshub | 10/13/2021 5:45:21 PM |
Nope, but long term hopefully be good! Ill | Atown62 | investorshub | 10/13/2021 5:44:25 PM |
looks like the public doesn't like dilution... | Myth | investorshub | 10/13/2021 5:33:47 PM |
wow....tanking again.... | Myth | investorshub | 10/13/2021 2:45:32 PM |
whytestocks: $SRPT News Article - Sarepta Therapeutics Announces Proposed $500,000,000 Public Offeri | whytestocks | investorshangout | 10/12/2021 8:35:51 PM |
Again? I love 50% gains | Atown62 | investorshub | 10/12/2021 12:00:45 AM |
blood red again.... | Myth | investorshub | 10/11/2021 8:01:14 PM |
There is absolutely no truth to this at | Atown62 | investorshub | 10/11/2021 7:18:18 PM |
I do just fine, dude... | Myth | investorshub | 10/11/2021 1:44:33 PM |
Dude you have to know when to trade em. | girlfriend | investorshub | 10/11/2021 1:43:46 PM |
Yeah but dropping well my core is all | girlfriend | investorshub | 10/11/2021 1:43:19 PM |
lol....now that's funny.... | Myth | investorshub | 10/11/2021 1:39:41 PM |
Good news today. | Atown62 | investorshub | 10/11/2021 1:19:48 PM |
Hell yes! Go $SRPT! Well see what Monday brings! | Atown62 | investorshub | 10/09/2021 2:50:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
2024-06-26 10:06:00 ET When one player stumbles in a high-stakes competition, it's often to the glee of the other contenders. In mid-June, Pfizer 's (NYSE: PFE) gene-therapy candidate to treat Duchenne muscular dystrophy (DMD) didn't hit the mark in a late-stage clinical trial; it'd...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.2% to $126.57 on volume of 604,432,871 shares American Rebel Holdings Inc. (AREB) rose 152.5% to $0.76 on volume of 367,740,589 shares Sirius XM Holdings Inc. (SIRI) rose 1.0% to $2.93 on volume of 329...
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is one of today's top gainers. The company's shares have moved 34.64% on the day to $166.22. Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies...